ArticleScientific reports2025
Chaotic Lévy and adaptive restart enhance the Manta Ray foraging optimizer for gene feature selection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Swarm-based optimization algorithms often face challenges in maintaining an effective exploration-exploitation balance in high-dimensional search spaces. Manta Ray Foraging Optimization (MRFO), while competitive, is hindered by static parameter settings and premature convergence. This study introduces CLA-MRFO, an adaptive variant incorporating chaotic Lévy flight modulation, phase-aware memory, and an entropy-informed restart strategy to enhance search dynamics. On the CEC'17 benchmark suite, CLA-MRFO achieved the lowest mean error on 23 of 29 functions, with an average performance gain of 31.7% over the next best algorithm; statistical validation via the Friedman test confirmed the significance of these results ([Formula: see text]). To examine practical utility, CLA-MRFO was applied to a high-dimensional leukemia gene selection task, where it identified ultra-compact subsets (≤5% of original features) of biologically coherent genes with established roles in leukemia pathogenesis. These subsets enabled a mean F
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.